Medical Devices & Consumables
Global Immunology-Oncology Elisa Kits Market Research Report 2026
- Feb 24, 26
- ID: 717906
- Pages: 115
- Figures: 114
- Views: 1
This report delivers a comprehensive overview of the global Immunology-Oncology Elisa Kits market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immunology-Oncology Elisa Kits. The Immunology-Oncology Elisa Kits market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Immunology-Oncology Elisa Kits market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Immunology-Oncology Elisa Kits manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Techne Corporation (R&D Systems)
Abcam
BioLegend (part of PerkinElmer)
BD Biosciences
MilliporeSigma (Merck KGaA)
Enzo Life Sciences
RayBiotech Life, Inc.
ELISAGEN Biotech
Creative Diagnostics
Segment by Type
Direct ELISA Kit
Indirect ELISA Kit
by Application
Cancer Diagnosis
Pharmaceutical Industry
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Immunology-Oncology Elisa Kits manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Immunology-Oncology Elisa Kits sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Immunology-Oncology Elisa Kits market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Immunology-Oncology Elisa Kits manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Techne Corporation (R&D Systems)
Abcam
BioLegend (part of PerkinElmer)
BD Biosciences
MilliporeSigma (Merck KGaA)
Enzo Life Sciences
RayBiotech Life, Inc.
ELISAGEN Biotech
Creative Diagnostics
Segment by Type
Direct ELISA Kit
Indirect ELISA Kit
by Application
Cancer Diagnosis
Pharmaceutical Industry
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Immunology-Oncology Elisa Kits manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Immunology-Oncology Elisa Kits sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Immunology-Oncology Elisa Kits Market Overview
1.1 Product Definition
1.2 Immunology-Oncology Elisa Kits by Type
1.2.1 Global Immunology-Oncology Elisa Kits Market Value by Type: 2025 vs 2032
1.2.2 Direct ELISA Kit
1.2.3 Indirect ELISA Kit
1.3 Immunology-Oncology Elisa Kits by Application
1.3.1 Global Immunology-Oncology Elisa Kits Market Value by Application: 2025 vs 2032
1.3.2 Cancer Diagnosis
1.3.3 Pharmaceutical Industry
1.3.4 Other
1.4 Global Immunology-Oncology Elisa Kits Market Size Estimates and Forecasts
1.4.1 Global Immunology-Oncology Elisa Kits Revenue 2021–2032
1.4.2 Global Immunology-Oncology Elisa Kits Sales 2021–2032
1.4.3 Global Immunology-Oncology Elisa Kits Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Immunology-Oncology Elisa Kits Market Competition by Manufacturers
2.1 Global Immunology-Oncology Elisa Kits Sales Market Share by Manufacturers (2021–2026)
2.2 Global Immunology-Oncology Elisa Kits Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Immunology-Oncology Elisa Kits Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Immunology-Oncology Elisa Kits, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Immunology-Oncology Elisa Kits, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Immunology-Oncology Elisa Kits, Product Types and Applications
2.7 Global Key Manufacturers of Immunology-Oncology Elisa Kits, Date of Entry into the Industry
2.8 Global Immunology-Oncology Elisa Kits Market Competitive Situation and Trends
2.8.1 Global Immunology-Oncology Elisa Kits Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Immunology-Oncology Elisa Kits Players Market Share by Revenue
2.8.3 Global Immunology-Oncology Elisa Kits Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Immunology-Oncology Elisa Kits Market Scenario by Region
3.1 Global Immunology-Oncology Elisa Kits Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Immunology-Oncology Elisa Kits Sales by Region: 2021–2032
3.2.1 Global Immunology-Oncology Elisa Kits Sales by Region: 2021–2026
3.2.2 Global Immunology-Oncology Elisa Kits Sales by Region: 2027–2032
3.3 Global Immunology-Oncology Elisa Kits Revenue by Region: 2021–2032
3.3.1 Global Immunology-Oncology Elisa Kits Revenue by Region: 2021–2026
3.3.2 Global Immunology-Oncology Elisa Kits Revenue by Region: 2027–2032
3.4 North America Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.4.1 North America Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.4.3 North America Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.5.1 Europe Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.5.3 Europe Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immunology-Oncology Elisa Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Immunology-Oncology Elisa Kits Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Immunology-Oncology Elisa Kits Sales by Region (2021–2032)
3.6.3 Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.7.1 Latin America Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.7.3 Latin America Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.8.3 Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021–2032)
4.1.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021–2026)
4.1.2 Global Immunology-Oncology Elisa Kits Sales by Type (2027–2032)
4.1.3 Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021–2032)
4.2 Global Immunology-Oncology Elisa Kits Revenue by Type (2021–2032)
4.2.1 Global Immunology-Oncology Elisa Kits Revenue by Type (2021–2026)
4.2.2 Global Immunology-Oncology Elisa Kits Revenue by Type (2027–2032)
4.2.3 Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021–2032)
4.3 Global Immunology-Oncology Elisa Kits Price by Type (2021–2032)
5 Segment by Application
5.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021–2032)
5.1.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021–2026)
5.1.2 Global Immunology-Oncology Elisa Kits Sales by Application (2027–2032)
5.1.3 Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021–2032)
5.2 Global Immunology-Oncology Elisa Kits Revenue by Application (2021–2032)
5.2.1 Global Immunology-Oncology Elisa Kits Revenue by Application (2021–2026)
5.2.2 Global Immunology-Oncology Elisa Kits Revenue by Application (2027–2032)
5.2.3 Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021–2032)
5.3 Global Immunology-Oncology Elisa Kits Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Bio-Techne Corporation (R&D Systems)
6.2.1 Bio-Techne Corporation (R&D Systems) Company Information
6.2.2 Bio-Techne Corporation (R&D Systems) Description and Business Overview
6.2.3 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product Portfolio
6.2.5 Bio-Techne Corporation (R&D Systems) Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abcam Immunology-Oncology Elisa Kits Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 BioLegend (part of PerkinElmer)
6.4.1 BioLegend (part of PerkinElmer) Company Information
6.4.2 BioLegend (part of PerkinElmer) Description and Business Overview
6.4.3 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product Portfolio
6.4.5 BioLegend (part of PerkinElmer) Recent Developments/Updates
6.5 BD Biosciences
6.5.1 BD Biosciences Company Information
6.5.2 BD Biosciences Description and Business Overview
6.5.3 BD Biosciences Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BD Biosciences Immunology-Oncology Elisa Kits Product Portfolio
6.5.5 BD Biosciences Recent Developments/Updates
6.6 MilliporeSigma (Merck KGaA)
6.6.1 MilliporeSigma (Merck KGaA) Company Information
6.6.2 MilliporeSigma (Merck KGaA) Description and Business Overview
6.6.3 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product Portfolio
6.6.5 MilliporeSigma (Merck KGaA) Recent Developments/Updates
6.7 Enzo Life Sciences
6.7.1 Enzo Life Sciences Company Information
6.7.2 Enzo Life Sciences Description and Business Overview
6.7.3 Enzo Life Sciences Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Enzo Life Sciences Immunology-Oncology Elisa Kits Product Portfolio
6.7.5 Enzo Life Sciences Recent Developments/Updates
6.8 RayBiotech Life, Inc.
6.8.1 RayBiotech Life, Inc. Company Information
6.8.2 RayBiotech Life, Inc. Description and Business Overview
6.8.3 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product Portfolio
6.8.5 RayBiotech Life, Inc. Recent Developments/Updates
6.9 ELISAGEN Biotech
6.9.1 ELISAGEN Biotech Company Information
6.9.2 ELISAGEN Biotech Description and Business Overview
6.9.3 ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 ELISAGEN Biotech Immunology-Oncology Elisa Kits Product Portfolio
6.9.5 ELISAGEN Biotech Recent Developments/Updates
6.10 Creative Diagnostics
6.10.1 Creative Diagnostics Company Information
6.10.2 Creative Diagnostics Description and Business Overview
6.10.3 Creative Diagnostics Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Creative Diagnostics Immunology-Oncology Elisa Kits Product Portfolio
6.10.5 Creative Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immunology-Oncology Elisa Kits Industry Chain Analysis
7.2 Immunology-Oncology Elisa Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immunology-Oncology Elisa Kits Production Mode & Process Analysis
7.4 Immunology-Oncology Elisa Kits Sales and Marketing
7.4.1 Immunology-Oncology Elisa Kits Sales Channels
7.4.2 Immunology-Oncology Elisa Kits Distributors
7.5 Immunology-Oncology Elisa Kits Customer Analysis
8 Immunology-Oncology Elisa Kits Market Dynamics
8.1 Immunology-Oncology Elisa Kits Industry Trends
8.2 Immunology-Oncology Elisa Kits Market Drivers
8.3 Immunology-Oncology Elisa Kits Market Challenges
8.4 Immunology-Oncology Elisa Kits Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Immunology-Oncology Elisa Kits by Type
1.2.1 Global Immunology-Oncology Elisa Kits Market Value by Type: 2025 vs 2032
1.2.2 Direct ELISA Kit
1.2.3 Indirect ELISA Kit
1.3 Immunology-Oncology Elisa Kits by Application
1.3.1 Global Immunology-Oncology Elisa Kits Market Value by Application: 2025 vs 2032
1.3.2 Cancer Diagnosis
1.3.3 Pharmaceutical Industry
1.3.4 Other
1.4 Global Immunology-Oncology Elisa Kits Market Size Estimates and Forecasts
1.4.1 Global Immunology-Oncology Elisa Kits Revenue 2021–2032
1.4.2 Global Immunology-Oncology Elisa Kits Sales 2021–2032
1.4.3 Global Immunology-Oncology Elisa Kits Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Immunology-Oncology Elisa Kits Market Competition by Manufacturers
2.1 Global Immunology-Oncology Elisa Kits Sales Market Share by Manufacturers (2021–2026)
2.2 Global Immunology-Oncology Elisa Kits Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Immunology-Oncology Elisa Kits Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Immunology-Oncology Elisa Kits, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Immunology-Oncology Elisa Kits, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Immunology-Oncology Elisa Kits, Product Types and Applications
2.7 Global Key Manufacturers of Immunology-Oncology Elisa Kits, Date of Entry into the Industry
2.8 Global Immunology-Oncology Elisa Kits Market Competitive Situation and Trends
2.8.1 Global Immunology-Oncology Elisa Kits Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Immunology-Oncology Elisa Kits Players Market Share by Revenue
2.8.3 Global Immunology-Oncology Elisa Kits Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Immunology-Oncology Elisa Kits Market Scenario by Region
3.1 Global Immunology-Oncology Elisa Kits Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Immunology-Oncology Elisa Kits Sales by Region: 2021–2032
3.2.1 Global Immunology-Oncology Elisa Kits Sales by Region: 2021–2026
3.2.2 Global Immunology-Oncology Elisa Kits Sales by Region: 2027–2032
3.3 Global Immunology-Oncology Elisa Kits Revenue by Region: 2021–2032
3.3.1 Global Immunology-Oncology Elisa Kits Revenue by Region: 2021–2026
3.3.2 Global Immunology-Oncology Elisa Kits Revenue by Region: 2027–2032
3.4 North America Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.4.1 North America Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.4.3 North America Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.5.1 Europe Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.5.3 Europe Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immunology-Oncology Elisa Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Immunology-Oncology Elisa Kits Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Immunology-Oncology Elisa Kits Sales by Region (2021–2032)
3.6.3 Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.7.1 Latin America Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.7.3 Latin America Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.8.3 Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021–2032)
4.1.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021–2026)
4.1.2 Global Immunology-Oncology Elisa Kits Sales by Type (2027–2032)
4.1.3 Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021–2032)
4.2 Global Immunology-Oncology Elisa Kits Revenue by Type (2021–2032)
4.2.1 Global Immunology-Oncology Elisa Kits Revenue by Type (2021–2026)
4.2.2 Global Immunology-Oncology Elisa Kits Revenue by Type (2027–2032)
4.2.3 Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021–2032)
4.3 Global Immunology-Oncology Elisa Kits Price by Type (2021–2032)
5 Segment by Application
5.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021–2032)
5.1.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021–2026)
5.1.2 Global Immunology-Oncology Elisa Kits Sales by Application (2027–2032)
5.1.3 Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021–2032)
5.2 Global Immunology-Oncology Elisa Kits Revenue by Application (2021–2032)
5.2.1 Global Immunology-Oncology Elisa Kits Revenue by Application (2021–2026)
5.2.2 Global Immunology-Oncology Elisa Kits Revenue by Application (2027–2032)
5.2.3 Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021–2032)
5.3 Global Immunology-Oncology Elisa Kits Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Bio-Techne Corporation (R&D Systems)
6.2.1 Bio-Techne Corporation (R&D Systems) Company Information
6.2.2 Bio-Techne Corporation (R&D Systems) Description and Business Overview
6.2.3 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product Portfolio
6.2.5 Bio-Techne Corporation (R&D Systems) Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abcam Immunology-Oncology Elisa Kits Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 BioLegend (part of PerkinElmer)
6.4.1 BioLegend (part of PerkinElmer) Company Information
6.4.2 BioLegend (part of PerkinElmer) Description and Business Overview
6.4.3 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product Portfolio
6.4.5 BioLegend (part of PerkinElmer) Recent Developments/Updates
6.5 BD Biosciences
6.5.1 BD Biosciences Company Information
6.5.2 BD Biosciences Description and Business Overview
6.5.3 BD Biosciences Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BD Biosciences Immunology-Oncology Elisa Kits Product Portfolio
6.5.5 BD Biosciences Recent Developments/Updates
6.6 MilliporeSigma (Merck KGaA)
6.6.1 MilliporeSigma (Merck KGaA) Company Information
6.6.2 MilliporeSigma (Merck KGaA) Description and Business Overview
6.6.3 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product Portfolio
6.6.5 MilliporeSigma (Merck KGaA) Recent Developments/Updates
6.7 Enzo Life Sciences
6.7.1 Enzo Life Sciences Company Information
6.7.2 Enzo Life Sciences Description and Business Overview
6.7.3 Enzo Life Sciences Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Enzo Life Sciences Immunology-Oncology Elisa Kits Product Portfolio
6.7.5 Enzo Life Sciences Recent Developments/Updates
6.8 RayBiotech Life, Inc.
6.8.1 RayBiotech Life, Inc. Company Information
6.8.2 RayBiotech Life, Inc. Description and Business Overview
6.8.3 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product Portfolio
6.8.5 RayBiotech Life, Inc. Recent Developments/Updates
6.9 ELISAGEN Biotech
6.9.1 ELISAGEN Biotech Company Information
6.9.2 ELISAGEN Biotech Description and Business Overview
6.9.3 ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 ELISAGEN Biotech Immunology-Oncology Elisa Kits Product Portfolio
6.9.5 ELISAGEN Biotech Recent Developments/Updates
6.10 Creative Diagnostics
6.10.1 Creative Diagnostics Company Information
6.10.2 Creative Diagnostics Description and Business Overview
6.10.3 Creative Diagnostics Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Creative Diagnostics Immunology-Oncology Elisa Kits Product Portfolio
6.10.5 Creative Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immunology-Oncology Elisa Kits Industry Chain Analysis
7.2 Immunology-Oncology Elisa Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immunology-Oncology Elisa Kits Production Mode & Process Analysis
7.4 Immunology-Oncology Elisa Kits Sales and Marketing
7.4.1 Immunology-Oncology Elisa Kits Sales Channels
7.4.2 Immunology-Oncology Elisa Kits Distributors
7.5 Immunology-Oncology Elisa Kits Customer Analysis
8 Immunology-Oncology Elisa Kits Market Dynamics
8.1 Immunology-Oncology Elisa Kits Industry Trends
8.2 Immunology-Oncology Elisa Kits Market Drivers
8.3 Immunology-Oncology Elisa Kits Market Challenges
8.4 Immunology-Oncology Elisa Kits Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Immunology-Oncology Elisa Kits Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Immunology-Oncology Elisa Kits Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Immunology-Oncology Elisa Kits Market Competitive Situation by Manufacturers in 2025
Table 4. Global Immunology-Oncology Elisa Kits Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Immunology-Oncology Elisa Kits Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Immunology-Oncology Elisa Kits Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Immunology-Oncology Elisa Kits Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Immunology-Oncology Elisa Kits, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Immunology-Oncology Elisa Kits, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Immunology-Oncology Elisa Kits, Product Types and Applications
Table 12. Global Key Manufacturers of Immunology-Oncology Elisa Kits, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immunology-Oncology Elisa Kits Companies by Tier (Tier 1, Tier 2, Tier 3), based on Immunology-Oncology Elisa Kits Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Immunology-Oncology Elisa Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Immunology-Oncology Elisa Kits Sales by Region (K Units), 2021–2026
Table 18. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2021–2026)
Table 19. Global Immunology-Oncology Elisa Kits Sales by Region (K Units), 2027–2032
Table 20. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2027–2032)
Table 21. Global Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2021–2026
Table 22. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021–2026)
Table 23. Global Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2027–2032
Table 24. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2027–2032)
Table 25. North America Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
Table 27. North America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
Table 28. North America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
Table 29. North America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
Table 32. Europe Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
Table 33. Europe Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Immunology-Oncology Elisa Kits Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Immunology-Oncology Elisa Kits Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
Table 42. Latin America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
Table 43. Latin America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
Table 50. Global Immunology-Oncology Elisa Kits Sales (K Units) by Type (2021–2026)
Table 51. Global Immunology-Oncology Elisa Kits Sales (K Units) by Type (2027–2032)
Table 52. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021–2026)
Table 53. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2027–2032)
Table 54. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021–2026)
Table 57. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2027–2032)
Table 58. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Type (2021–2026)
Table 59. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Type (2027–2032)
Table 60. Global Immunology-Oncology Elisa Kits Sales (K Units) by Application (2021–2026)
Table 61. Global Immunology-Oncology Elisa Kits Sales (K Units) by Application (2027–2032)
Table 62. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021–2026)
Table 63. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2027–2032)
Table 64. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021–2026)
Table 67. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2027–2032)
Table 68. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Application (2021–2026)
Table 69. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Application (2027–2032)
Table 70. Thermo Fisher Scientific Company Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. Bio-Techne Corporation (R&D Systems) Company Information
Table 76. Bio-Techne Corporation (R&D Systems) Description and Business Overview
Table 77. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product
Table 79. Bio-Techne Corporation (R&D Systems) Recent Developments/Updates
Table 80. Abcam Company Information
Table 81. Abcam Description and Business Overview
Table 82. Abcam Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Abcam Immunology-Oncology Elisa Kits Product
Table 84. Abcam Recent Developments/Updates
Table 85. BioLegend (part of PerkinElmer) Company Information
Table 86. BioLegend (part of PerkinElmer) Description and Business Overview
Table 87. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product
Table 89. BioLegend (part of PerkinElmer) Recent Developments/Updates
Table 90. BD Biosciences Company Information
Table 91. BD Biosciences Description and Business Overview
Table 92. BD Biosciences Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. BD Biosciences Immunology-Oncology Elisa Kits Product
Table 94. BD Biosciences Recent Developments/Updates
Table 95. MilliporeSigma (Merck KGaA) Company Information
Table 96. MilliporeSigma (Merck KGaA) Description and Business Overview
Table 97. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product
Table 99. MilliporeSigma (Merck KGaA) Recent Developments/Updates
Table 100. Enzo Life Sciences Company Information
Table 101. Enzo Life Sciences Description and Business Overview
Table 102. Enzo Life Sciences Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Enzo Life Sciences Immunology-Oncology Elisa Kits Product
Table 104. Enzo Life Sciences Recent Developments/Updates
Table 105. RayBiotech Life, Inc. Company Information
Table 106. RayBiotech Life, Inc. Description and Business Overview
Table 107. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product
Table 109. RayBiotech Life, Inc. Recent Developments/Updates
Table 110. ELISAGEN Biotech Company Information
Table 111. ELISAGEN Biotech Description and Business Overview
Table 112. ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. ELISAGEN Biotech Immunology-Oncology Elisa Kits Product
Table 114. ELISAGEN Biotech Recent Developments/Updates
Table 115. Creative Diagnostics Company Information
Table 116. Creative Diagnostics Description and Business Overview
Table 117. Creative Diagnostics Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Creative Diagnostics Immunology-Oncology Elisa Kits Product
Table 119. Creative Diagnostics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Immunology-Oncology Elisa Kits Distributors List
Table 123. Immunology-Oncology Elisa Kits Customers List
Table 124. Immunology-Oncology Elisa Kits Market Trends
Table 125. Immunology-Oncology Elisa Kits Market Drivers
Table 126. Immunology-Oncology Elisa Kits Market Challenges
Table 127. Immunology-Oncology Elisa Kits Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Immunology-Oncology Elisa Kits
Figure 2. Global Immunology-Oncology Elisa Kits Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Immunology-Oncology Elisa Kits Market Share by Type: 2025 & 2032
Figure 4. Direct ELISA Kit Product Picture
Figure 5. Indirect ELISA Kit Product Picture
Figure 6. Global Immunology-Oncology Elisa Kits Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Immunology-Oncology Elisa Kits Market Share by Application: 2025 & 2032
Figure 8. Cancer Diagnosis
Figure 9. Pharmaceutical Industry
Figure 10. Other
Figure 11. Global Immunology-Oncology Elisa Kits Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Immunology-Oncology Elisa Kits Market Size (US$ Million), 2021–2032
Figure 13. Global Immunology-Oncology Elisa Kits Sales (K Units), 2021–2032
Figure 14. Global Immunology-Oncology Elisa Kits Average Price (US$/Unit), 2021–2032
Figure 15. Immunology-Oncology Elisa Kits Report Years Considered
Figure 16. Immunology-Oncology Elisa Kits Sales Share by Manufacturers in 2025
Figure 17. Global Immunology-Oncology Elisa Kits Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Immunology-Oncology Elisa Kits Players: Market Share by Revenue in Immunology-Oncology Elisa Kits in 2025
Figure 19. Immunology-Oncology Elisa Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Immunology-Oncology Elisa Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
Figure 22. North America Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
Figure 23. United States Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
Figure 26. Europe Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
Figure 27. Germany Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Immunology-Oncology Elisa Kits Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021–2032)
Figure 34. China Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
Figure 42. Latin America Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Immunology-Oncology Elisa Kits by Type (2021–2032)
Figure 53. Global Revenue Market Share of Immunology-Oncology Elisa Kits by Type (2021–2032)
Figure 54. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Immunology-Oncology Elisa Kits by Application (2021–2032)
Figure 56. Global Revenue Market Share of Immunology-Oncology Elisa Kits by Application (2021–2032)
Figure 57. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Application (2021–2032)
Figure 58. Immunology-Oncology Elisa Kits Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Immunology-Oncology Elisa Kits Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Immunology-Oncology Elisa Kits Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Immunology-Oncology Elisa Kits Market Competitive Situation by Manufacturers in 2025
Table 4. Global Immunology-Oncology Elisa Kits Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Immunology-Oncology Elisa Kits Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Immunology-Oncology Elisa Kits Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Immunology-Oncology Elisa Kits Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Immunology-Oncology Elisa Kits, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Immunology-Oncology Elisa Kits, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Immunology-Oncology Elisa Kits, Product Types and Applications
Table 12. Global Key Manufacturers of Immunology-Oncology Elisa Kits, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Immunology-Oncology Elisa Kits Companies by Tier (Tier 1, Tier 2, Tier 3), based on Immunology-Oncology Elisa Kits Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Immunology-Oncology Elisa Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Immunology-Oncology Elisa Kits Sales by Region (K Units), 2021–2026
Table 18. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2021–2026)
Table 19. Global Immunology-Oncology Elisa Kits Sales by Region (K Units), 2027–2032
Table 20. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2027–2032)
Table 21. Global Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2021–2026
Table 22. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021–2026)
Table 23. Global Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2027–2032
Table 24. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2027–2032)
Table 25. North America Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
Table 27. North America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
Table 28. North America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
Table 29. North America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
Table 32. Europe Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
Table 33. Europe Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Immunology-Oncology Elisa Kits Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Immunology-Oncology Elisa Kits Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
Table 42. Latin America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
Table 43. Latin America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
Table 50. Global Immunology-Oncology Elisa Kits Sales (K Units) by Type (2021–2026)
Table 51. Global Immunology-Oncology Elisa Kits Sales (K Units) by Type (2027–2032)
Table 52. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021–2026)
Table 53. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2027–2032)
Table 54. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021–2026)
Table 57. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2027–2032)
Table 58. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Type (2021–2026)
Table 59. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Type (2027–2032)
Table 60. Global Immunology-Oncology Elisa Kits Sales (K Units) by Application (2021–2026)
Table 61. Global Immunology-Oncology Elisa Kits Sales (K Units) by Application (2027–2032)
Table 62. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021–2026)
Table 63. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2027–2032)
Table 64. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021–2026)
Table 67. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2027–2032)
Table 68. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Application (2021–2026)
Table 69. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Application (2027–2032)
Table 70. Thermo Fisher Scientific Company Information
Table 71. Thermo Fisher Scientific Description and Business Overview
Table 72. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product
Table 74. Thermo Fisher Scientific Recent Developments/Updates
Table 75. Bio-Techne Corporation (R&D Systems) Company Information
Table 76. Bio-Techne Corporation (R&D Systems) Description and Business Overview
Table 77. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product
Table 79. Bio-Techne Corporation (R&D Systems) Recent Developments/Updates
Table 80. Abcam Company Information
Table 81. Abcam Description and Business Overview
Table 82. Abcam Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Abcam Immunology-Oncology Elisa Kits Product
Table 84. Abcam Recent Developments/Updates
Table 85. BioLegend (part of PerkinElmer) Company Information
Table 86. BioLegend (part of PerkinElmer) Description and Business Overview
Table 87. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product
Table 89. BioLegend (part of PerkinElmer) Recent Developments/Updates
Table 90. BD Biosciences Company Information
Table 91. BD Biosciences Description and Business Overview
Table 92. BD Biosciences Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. BD Biosciences Immunology-Oncology Elisa Kits Product
Table 94. BD Biosciences Recent Developments/Updates
Table 95. MilliporeSigma (Merck KGaA) Company Information
Table 96. MilliporeSigma (Merck KGaA) Description and Business Overview
Table 97. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product
Table 99. MilliporeSigma (Merck KGaA) Recent Developments/Updates
Table 100. Enzo Life Sciences Company Information
Table 101. Enzo Life Sciences Description and Business Overview
Table 102. Enzo Life Sciences Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Enzo Life Sciences Immunology-Oncology Elisa Kits Product
Table 104. Enzo Life Sciences Recent Developments/Updates
Table 105. RayBiotech Life, Inc. Company Information
Table 106. RayBiotech Life, Inc. Description and Business Overview
Table 107. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product
Table 109. RayBiotech Life, Inc. Recent Developments/Updates
Table 110. ELISAGEN Biotech Company Information
Table 111. ELISAGEN Biotech Description and Business Overview
Table 112. ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. ELISAGEN Biotech Immunology-Oncology Elisa Kits Product
Table 114. ELISAGEN Biotech Recent Developments/Updates
Table 115. Creative Diagnostics Company Information
Table 116. Creative Diagnostics Description and Business Overview
Table 117. Creative Diagnostics Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Creative Diagnostics Immunology-Oncology Elisa Kits Product
Table 119. Creative Diagnostics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Immunology-Oncology Elisa Kits Distributors List
Table 123. Immunology-Oncology Elisa Kits Customers List
Table 124. Immunology-Oncology Elisa Kits Market Trends
Table 125. Immunology-Oncology Elisa Kits Market Drivers
Table 126. Immunology-Oncology Elisa Kits Market Challenges
Table 127. Immunology-Oncology Elisa Kits Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Immunology-Oncology Elisa Kits
Figure 2. Global Immunology-Oncology Elisa Kits Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Immunology-Oncology Elisa Kits Market Share by Type: 2025 & 2032
Figure 4. Direct ELISA Kit Product Picture
Figure 5. Indirect ELISA Kit Product Picture
Figure 6. Global Immunology-Oncology Elisa Kits Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Immunology-Oncology Elisa Kits Market Share by Application: 2025 & 2032
Figure 8. Cancer Diagnosis
Figure 9. Pharmaceutical Industry
Figure 10. Other
Figure 11. Global Immunology-Oncology Elisa Kits Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Immunology-Oncology Elisa Kits Market Size (US$ Million), 2021–2032
Figure 13. Global Immunology-Oncology Elisa Kits Sales (K Units), 2021–2032
Figure 14. Global Immunology-Oncology Elisa Kits Average Price (US$/Unit), 2021–2032
Figure 15. Immunology-Oncology Elisa Kits Report Years Considered
Figure 16. Immunology-Oncology Elisa Kits Sales Share by Manufacturers in 2025
Figure 17. Global Immunology-Oncology Elisa Kits Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Immunology-Oncology Elisa Kits Players: Market Share by Revenue in Immunology-Oncology Elisa Kits in 2025
Figure 19. Immunology-Oncology Elisa Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Immunology-Oncology Elisa Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
Figure 22. North America Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
Figure 23. United States Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
Figure 26. Europe Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
Figure 27. Germany Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Immunology-Oncology Elisa Kits Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021–2032)
Figure 34. China Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
Figure 42. Latin America Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Immunology-Oncology Elisa Kits by Type (2021–2032)
Figure 53. Global Revenue Market Share of Immunology-Oncology Elisa Kits by Type (2021–2032)
Figure 54. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Immunology-Oncology Elisa Kits by Application (2021–2032)
Figure 56. Global Revenue Market Share of Immunology-Oncology Elisa Kits by Application (2021–2032)
Figure 57. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Application (2021–2032)
Figure 58. Immunology-Oncology Elisa Kits Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232